Sue Cammarata, MD, explains the advantages that delafloxcin has over other fluoroquinolones.
Sue Cammarata, MD, CMO of Melinta Therapeutics, explains the advantages that delafloxcin has over other available fluoroquinolones. When it comes to adverse events, other fluoroquinolones are known to cause heart arrhythmias, cause reactions in sunshine, as well as liver or sugar/glucose abnormalities, where delafloxcin does not.
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.